CEREBRAL lymphatic dysfunction is emerging as a promising therapeutic target in Alzheimer’s disease treatment and research.

More research is necessary to understand cerebral oxygen consumption as a predictive biomarker for brain atrophy in multiple sclerosis (MS); however, this study found that mitochondrial dysfunction ...

“[...] the associations between common non-invasive measures of cardiovascular health (e.g., blood pressure) and risk of dementia are not well-established ...